<?xml version="1.0" encoding="utf-8"?>


  
  
  




<!--
Sehr geehrter Besucher,

dies ist ein so genannter "RSS-Feed". Er ist nicht zum Lesen im Klartext
gedacht, sondern zum Abonnieren von News der Website des Max Dellbrück
Centrums
(http://www.mdc-berlin.de/).

Genauere Informationen zu RSS-Feeds finden Sie unter http://de.wikipedia.org/wiki/RSS
-->
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>RSS-Feed der Pressenachrichten</title>
  <link>http://www.mdc-berlin.de/</link>
 <atom:link href='http://www.mdc-berlin.de/en/globals/rssFeeds/pressRssFeed.xml' rel="self" type="application/rss+xml" />
  <description>Nachrichten aus dem Bereich "Presse" des Max-Dellbrück-Zentrums </description>
  <language>en</language>
  <generator>Infopark CMS Fiona 6.72</generator>
  <copyright>© 1994-2011 MDC-Berlin</copyright>
  <docs>http://www.rssboard.org/rss-specification</docs>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <sy:updateFrequency>1</sy:updateFrequency>
  
  <pubDate>Wed, 16 May 2012 14:12:35 GMT</pubDate>
  <lastBuildDate>Wed, 16 May 2012 14:12:35 GMT</lastBuildDate>
    
    <item>
        <title>Max Delbrück Center Wins EUR 1.8 Million Grant by the Helmholtz Association for a German-Israeli Research School</title>
        <description>&lt;p&gt;The Max Delbrück Center for Molecular
Medicine (MDC) Berlin-Buch has long standing
collaborative relations with two top Israeli universities: Technion
– Israel Institute of Technology in Haifa and The Hebrew University of
Jerusalem (HUJI). Now the MDC and its Israeli partners have succeeded in
acquiring a grant of EUR 1.8 million over 6 years for the joint German-Israeli
Helmholtz Research School “Frontiers in Cell Signaling &amp; Gene Regulation” (SignGene). The grant is endowed by the Initiative and
Networking Fund of the Helmholtz Association. Further partners
are Humboldt-Universität zu Berlin and Charité –
Universitätsmedizin Berlin. The Research School is an international PhD
training program for young scientists, who will be working on joint
German-Israeli projects. These enable closer collaboration between research
groups from Berlin, Haifa and Jerusalem on current topics of modern molecular
medicine. Helmholtz Research Schools provide doctoral training to 25
outstanding young doctoral students to conduct research on a specific topic.&lt;/p&gt;

</description>
        <link>http://www.mdc-berlin.de/en/news/2012/20120503-max_delbr_ck_center_wins_eur_1_8_million_g/index.html</link>
        <guid isPermaLink="true">http://www.mdc-berlin.de/en/news/2012/20120503-max_delbr_ck_center_wins_eur_1_8_million_g/index.html</guid>
        <pubDate>Thu, 03 May 2012 02:00:00 GMT</pubDate>
    </item>
    
    <item>
        <title>Gene Mutation Leads to Impairment of Two Senses: Touch and Hearing</title>
        <description>&lt;p&gt;People with good hearing also have a keen sense of touch; people
with impaired hearing generally have an impaired sense of touch. Extensive data
supporting this hypothesis was presented by Dr. Henning Frenzel and Professor
Gary R. Lewin of the Max Delbrück Center for Molecular Medicine (MDC)
Berlin-Buch, Germany. The two researchers showed that both senses – hearing and
touch – have a common genetic basis. In patients with Usher syndrome, a
hereditary form of deafness accompanied by impaired vision, they discovered a
gene mutation that is also causative for the patients’ impaired touch
sensitivity. The examination was preceded by various studies, including studies
with healthy identical and non-identical human twins (PloS Biology, doi:10.1371/journal.pbio.1001318)*.
In total, the researchers assessed sensory function in 518 volunteers.&lt;/p&gt;

</description>
        <link>http://www.mdc-berlin.de/en/news/2012/20120430-gene_mutation_leads_to_impairment_of_two_s/index.html</link>
        <guid isPermaLink="true">http://www.mdc-berlin.de/en/news/2012/20120430-gene_mutation_leads_to_impairment_of_two_s/index.html</guid>
        <pubDate>Mon, 30 Apr 2012 02:00:00 GMT</pubDate>
    </item>
    
    <item>
        <title>MDC-Researchers Elucidate Molecular Mechanism Contributing to Severe Forms of Cardiomyopathy</title>
        <description>&lt;p&gt;Cardiomyopathy comprises a deterioration of the heart muscle
that affects the organ's ability to efficiently pump blood through the body.
Previously researchers have tied forms of the disease to the alternative
splicing of titin, a giant protein that determines
the structure and biomechanical properties of the heart, but the molecular
mechanism remained unknown. Professor Michael Gotthardt and Professor Norbert Hübner of the Max Delbrück Center
for Molecular Medicine (MDC) Berlin-Buch, Germany,
and colleagues have found that the RNA binding motif protein 20 (RBM20), a gene
previously tied to hereditary cardiomyopathy, regulates titin
splicing. Understanding this molecular mechanism behind heart function and
failure, could lead to more efficient molecular diagnosis and therapies for
this sometimes insidious disease (Nature Medicine, &lt;a href=&quot;http://dx.doi.org/10.1038/nm.2693xxx).*&quot;&gt;http://dx.doi.org/10.1038/nm.2693xxx).*&lt;/a&gt;
&lt;/p&gt;

</description>
        <link>http://www.mdc-berlin.de/en/news/2012/20120328-mdc-researchers_elucidate_molecular_mechan/index.html</link>
        <guid isPermaLink="true">http://www.mdc-berlin.de/en/news/2012/20120328-mdc-researchers_elucidate_molecular_mechan/index.html</guid>
        <pubDate>Wed, 28 Mar 2012 02:00:00 GMT</pubDate>
    </item>
    
</channel>
</rss>


